Urmila Hansraj Sharma's Insider Trades & SAST Disclosures
Urmila Hansraj Sharma's most recent trade in Raymed Labs Ltd. was a Acquisition of 200,800 Equity Shares done at an average price of Rs. 3 . Disclosure was reported to the exchange on Feb. 19, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Urmila Hansraj Sharma's has made SAST transactions in Raymed Labs Ltd. recently where a Acquisition of 202,008 shares done . Disclosure was reported to the exchange on Feb. 18, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Raymed Labs | Urmila Hansraj Sharma | Promoter | Acquisition | 19 Feb 2025 | 200,800 | 200,800 (4.73%) | 4.70% | 3 | 602,400 | 17 Feb 2025 17 Feb 2025 |
Insider Trading | Equity Shares | Off Market |
| Raymed Labs | Urmila Hansraj Sharma | Promoter | Acquisition | 20 Mar 2025 | 202,008 | 202,008 (4.73%) | 4.73% | - | 17 Feb 2025 17 Feb 2025 |
SAST (29(1)) | - | Off Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.